Sandoz is the global leader in generic and biosimilar medicines, driven by a growth strategy rooted in its mission to pioneer access to medicines for patients. More than 20,000 employees representing over 100 nationalities work together to ensure that more than one billion patients have access to Sandoz treatments, generating substantial savings for healthcare systems worldwide while creating an even greater social impact.
Its industry-leading portfolio of approximately 1,300 products spans a broad range of therapeutic areas, from the common cold to cancer. Headquartered in Basel, Switzerland, the company draws on a heritage dating back to 1886. In 2026, Sandoz celebrates 20 years of leadership in biosimilars, 80 years of antibiotic manufacturing, and heritage. In 2025, Sandoz reported net sales of USD 11.1 billion.
